Tamsin Cargill
DPhil student
Brief biography:
I have been working with the Barnes group alongside my clinical training for several years. Much of my work has been focused on translational cellular immunology in immune mediated hepatobiliary disease. Recently I have been awarded a Welcome Trust Clinical Fellowship to undertake a PhD on HBV immunotherapy within the vaccine group.
Research Interests:
I am interested in harnessing cellular immunology to understand disease pathogenesis and develop novel treatment strategies for hepatobiliary conditions.
Current projects:
IgG4-Related Disease Study: Natural history and pathogenesis
Immunotherapy for chronic Hepatitis B infection
Recent publications
-
NK cells limit therapeutic vaccine-induced CD8+T cell immunity in a PD-L1-dependent manner.
Journal article
Diniz MO. et al, (2022), Science translational medicine, 14
-
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.
Journal article
Marjot T. et al, (2021), Journal of hepatology, 74, 567 - 577
-
The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases.
Journal article
Cargill T. and Culver EL., (2021), Frontiers in immunology, 12
-
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
Journal article
Webb GJ. et al, (2020), The Lancet Gastroenterology & Hepatology, 5, 1008 - 1016
-
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry.
Journal article
Moon AM. et al, (2020), Journal of hepatology, 73, 705 - 708